According to a market report by Lucintel, the future of the global veterinary infectious disease diagnostic market looks promising with opportunities in the reference laboratory, veterinary laboratory and clinic, point of care/ in house testing, and research institute and university end use industries. The global veterinary infectious disease diagnostic market is expected to reach an estimated $2.4 billion by 2028 with a CAGR of 8.6% from 2023 to 2028. The major drivers for this market are expenditure on animal health, upsurge in zoonotic disease occurrences, rising veterinarian count, technological progress in point-of-care diagnostics, and increasing disposable income levels in developing areas.
In this market, immunodiagnostics and
molecular diagnostics are the major technology segments. Lucintel forecast that
immunodiagnostics is expected to witness higher growth over the forecast period
due to an increase in the occurrence of infectious ailments among animals,
escalation in spending on animal healthcare, as well as the advantages linked
to the tests done on the animals.
Within this market, reference laboratories will remain the largest segment due to rising count of veterinary professionals, increasing rate of pet adoption, and significantly growing market for veterinary reference laboratories.
North America will remain the largest region over the forecast period due to escalating number of food-producing animals, rising consumption of meat and dairy products, increasing veterinary healthcare spending, and a surge in pet ownership in the region.
Heska Corporation, IDEXX, Neogen Corporation,
Randox Laboratories, Thermo Fisher Scientific, Virbac, Zoetis, Creative
Diagnostics, Eurofins Technologies, and Danaher are the major suppliers in the
global veterinary infectious disease diagnostic market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports:
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
4. Wheelchair Market :
5. 3D
Printing Medical Device Market:
8. Medical Lifting Sling
Market:
10. Stretcher Market:
No comments:
Post a Comment